Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

EGF Protein (AA 971-1023)

Cette protéine Recombinant EGF est produite dans Escherichia coli (E. coli).
N° du produit ABIN987814

Aperçu rapide pour EGF Protein (AA 971-1023) (ABIN987814)

Antigène

Voir toutes EGF Protéines
EGF (Epidermal Growth Factor (EGF))

Type de proteíne

Recombinant

Activité biologique

Active

Origine

  • 25
  • 15
  • 10
  • 4
  • 4
  • 1
Humain

Source

  • 40
  • 8
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
Escherichia coli (E. coli)

Pureté

> 95 % by SDS-PAGE analysis.
  • Attributs du protein

    AA 971-1023

    Attributs du produit

    ED50 <0.6 ng/mL, measured in a cell proliferation assay using Balb/3T3 mouse embryonic fibroblasts in serum-free medium and CellTiter-Glo cell viability assay, corresponding to a specific activity of >1.7 x 10^6 units/mg.
    AA 971-1023, expressed with an N-terminal Met

    niveau d'endotoxine

    < 0.1 ng/μg (1 EU/μg) determined by LAL test
  • Vous souhaitez d'autres options pour ce Protein ?

    !
    Découvrez nos protéines personnalisées prédéfinies et nos services de protéines sur mesure !

    Votre projet nécessite-t-il une personnalisation supplémentaire ? Contactez-nous et découvrez nos solutions protéiques sur mesure

  • Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Reconstituted in ddH2O at 100 μg/mL.

    Buffer

    Lyophilized after extensive dialysis against 10 mM PB, pH 7.0.

    Stock

    -80 °C

    Stockage commentaire

    Lyophilized recombinant human Epidermal Growth Factor (rhEGF) remains stable up to 12 months at -80 °C from date of receipt. Upon reconstitution, rhEGF should be stable up to 4 weeks at 4 °C or up to 6 months at -20 °C.

    Date de péremption

    12 months
  • Antigène

    EGF (Epidermal Growth Factor (EGF))

    Autre désignation

    Epidermal Growth Factor

    Sujet

    Epidermal Growth Factor (EGF) is a potent growth factor that stimulates the proliferation of various epidermal and epithelial cells. Additionally, EGF has been shown to inhibit gastric secretion, and to be involved in wound healing. EGF signals through a receptor known as c-erbB, which is a class I tyrosine kinase receptor. This receptor also binds with TGF-a and VGF (vaccinia virus growth factor). Recombinant human EGF is a 6.2 kDa globular protein containing 53 amino acid residues including 3 intramolecular disulfide-bonds. Recombinant human Epidermal Growth Factor (rhEGF) produced in E. coli is a non-glycosylated polypeptide chain of 54 amino acids. A fully biologically active molecule, rhEGF has a molecular mass of 6.2 kDa analyzed by reducing SDS-PAGE.
    Synonyms: Urogastrone, URG

    Poids moléculaire

    6.2kDa, observed by reducing SDS-PAGE.

    Pathways

    Signalisation NF-kappaB, Signalisation RTK, Fc-epsilon Receptor Signaling Pathway, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Regulation of Carbohydrate Metabolic Process, Hepatitis C, Protein targeting to Nucleus, Interaction of EGFR with phospholipase C-gamma, Thromboxane A2 Receptor Signaling, EGFR Downregulation
Vous êtes ici:
Chat with us!